David John Gregory Jennings

Tissue Science Laboratories Ltd. develops and markets tissue implant products. The company was founded on January 7, 1999 and is headquartered in Watford, the United Kingdom.

DySIS Medical Ltd. designs, develops, manufactures, and markets medical imaging systems. Its imaging systems assist clinicians with non-invasive, in-vivo detection of cancerous and pre-cancerous lesions and provides tools to aid medical practitioners in the detection, grading, and documentation of cervical neoplasia. The company was founded by Costas Balas in 2002 and is headquartered in Livingston, the United Kingdom.

RSM Tenon Group Plc provided entrepreneurial professional services. It offered audit and accounts, business finance, consultancy, corporate finance, corporate recovery, financial management, forensic accounting, information systems assurance, internal audit, outsourcing, risk management and software solutions. The company was founded in February 2000 and was headquartered in London, the United Kingdom.

Cerus Endovascular Ltd. designs and develops differentiated and proprietary interventional neuroradiology devices and delivery systems. The firm's products are used for the treatment of neurovascular diseases particularly intracranial aneurysms. The company was founded in 2011 and is headquartered in Oxford, the United Kingdom.

Part of Stryker Corp., Cerus Endovascular, Inc. is a company that specializes in transforming interventional neuroradiology. The company is based in Fremont, CA. The company offers innovative products such as the Contour Neurovascular System, Neqstent, and Intra-saccular Flow Diversion Cerus. The CEO of the company is Stephen Griffin.